MedDataX Logo

COVID-19 and Social Isolation and Loneliness Trial

NCT05228782 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2022-02-08

No results posted yet for this study

Summary

Social isolation and loneliness worsen older peoples' quality of life, risk of dementia, and contributes to 45,000 deaths/year in Canada - as much as smoking. Isolated people use the health care system more often, but have worse outcomes. Effective, inexpensive interventions exist but unfortunately they have not been implemented in Canada.

We partnered with the Australian developer of HOW R U?, an effective and feasible intervention that uses specially trained, older, hospital volunteers to provide peer support to combat isolation and loneliness in isolated older peers.

Little is known about older people's preferences for virtual care (telephone vs. video) nor their relative effectiveness. Thus we will compare two ways of delivering HOW R U: telephone support and a tested, secure user-friendly video conferencing app, aTouch Away® to a common control arm.

We also partnered with Emergency Medicine, Family Medicine, Geriatrics and Psychiatry to identify people who will benefit from peer support; and with Volunteer Services to recruit volunteers.

Conditions

  • Social Isolation
  • Loneliness
  • Geriatric

Interventions

OTHER

HOW R U? Intervention

HOW RU? intervention uses trained volunteer peers to provide strength-based support sessions weekly for 12 weeks.

Sponsors & Collaborators

  • Bolton Clarke Research Institute

    collaborator UNKNOWN

  • Sunnybrook Research Institute

    collaborator OTHER

  • North York General Hospital

    collaborator OTHER

  • King's College London

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Mount Sinai Hospital, Canada

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-11-01
Completion
2023-11-03

Countries

  • Canada

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05228782 on ClinicalTrials.gov